AMP releases consensus recommendations for CYP3A4 and CYP3A5

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

Related Keywords

Netherlands , United States , American , Dutch , Megan Craig , Karene Weck , Knowledgebase Pharm , Pharmacogenetics Pgx Working Group , Amp Pgx Working Group , University Of North Carolina At Chapel Hill , Royal Dutch Pharmacists Association , Professor Of Pathology Laboratory Medicine , College Of American Pathologists , Dutch Pharmacogenetics Working Group , Clinical Pharmacogenetics Implementation Consortium , European Society For Pharmacogenomics , Scientific Affairs For Pharmacogenetics At Agena Bioscience , Association For Molecular Pathology , Molecular Pathology , Joint Consensus Recommendation , American Pathologists , European Society , Personalized Therapy , Pharmacogenomics Knowledgebase , Working Group , Scientific Affairs , Agena Bioscience , Adjunct Professor , Clinical Pharmacology , Indiana University School , Practice Guidelines , Molecular Genetics , Laboratory Medicine , North Carolina , Assay , Genotyping , Pathology , Clinical Testing , Iagnostic , Iagnostics , Enetics , Healthcare , Laboratory , Medicine , Molecular Diagnostics , Pharmacogenetics , Pharmacogenomics ,